Aftercare is simple, mostly more water
GHK-Cu Timeline & What to Monitor Topical clinical trials of GHK-Cu generally measured endpoints at 8-12 weeks
290 A phase I/II trial is currently underway to evaluate the efficacy of JHU-083 in advanced solid tumors (NCT04471415) (Table 1)
References for this information: Biochemistry and Cell Biology , 2019, volume 92, issue 3, pages 270-289 Biochemical Pharmacology , 2003, Volume 66, issue 8, pages 1499-1503 International Journal of Biomedical Science , 2008, volume 4, issue 2, pages 89-96 Pharmacology Review, 2010, volume 4, issue 8, pages 118-126 Antioxidants and Redox Signaling , 2013, volume 19, issue 8, pages 813-822 Nutrients , 2019, volume 11, issue 9 Biomolecules , 2015, volume 5, issue 2, pages 545-589 Aging: Oxidative Stress and Dietary Antioxidants , 2014, pages 15-22 Asian Pacific Journal of Cancer Prevention, 2014, volume 15, issue 2, pages 561-568 Clinical, Cosmetic and Investigational Dermatology , 2017, volume 10, pages 147-153 British Society for Immunology , 2020, volume 160, issue 2, pages 116-125 Harvard T.H
If youre the kind of patient who loves the idea of cutting-edge science and biohacks, MOTS-c is one to watch
The supplement is made in Germany by veterinarians and pet experts
